Bray June 4
4 · Quince Therapeutics, Inc. · Filed Jun 6, 2025
Insider Transaction Report
Form 4
Bray June
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-06-04+27,000→ 27,000 totalExercise: $1.09Exp: 2035-06-04→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest 100% on the one-year anniversary of the grant date. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the issuer's Outside Director Compensation Policy.